Feb 25, 2026 07:00AM
Jan 5, 2026 07:02AM
Jan 5, 2026 07:00AM
Dec 15, 2025 07:03AM
Dec 15, 2025 07:00AM
Dec 1, 2025 07:02AM
Dec 1, 2025 07:00AM RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders' Equity Requirement
Nov 4, 2025 12:02PM
Nov 4, 2025 09:30AM
Nov 4, 2025 09:30AM
Nov 4, 2025 09:30AM
Oct 22, 2025 04:51PM
Oct 22, 2025 04:50PM
Oct 20, 2025 09:01AM Cumberland Pharmaceuticals invests $4 million in RedHill's Talicia business
Oct 20, 2025 09:00AM
Oct 6, 2025 08:01AM
Oct 6, 2025 08:00AM
Sep 29, 2025 07:02AM
Sep 29, 2025 07:00AM
Sep 5, 2025 07:00AM
Aug 20, 2025 09:03AM RedHill Biopharma wins $1.8M in legal costs from New York court
Aug 20, 2025 09:00AM
Aug 18, 2025 09:03AM
Aug 18, 2025 09:00AM
Jul 21, 2025 09:01AM
Jul 21, 2025 09:00AM
Jul 1, 2025 12:01PM
Jul 1, 2025 12:00PM RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer
May 13, 2025 07:00AM
May 2, 2025 07:00AM
Apr 28, 2025 07:05AM
Apr 28, 2025 07:03AM
Apr 17, 2025 04:08PM
Apr 17, 2025 04:01PM
Apr 16, 2025 07:02AM RedHill Biopharma's (RDHL) Positive Opaganib Weight Loss & Diabetes Data Published
Apr 16, 2025 07:00AM
Apr 10, 2025 07:48AM
Mar 18, 2025 07:00AM
Mar 18, 2025 07:00AM
Mar 12, 2025 07:00AM
Feb 27, 2025 07:00AM
Feb 25, 2025 07:04AM RedHill Biopharma (RDHL) Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties
Feb 25, 2025 07:00AM
Feb 4, 2025 07:02AM
Feb 4, 2025 07:00AM
Jan 21, 2025 07:00AM
Dec 10, 2024 07:06AM
Dec 10, 2024 07:00AM
Dec 2, 2024 07:00AM RedHill Biopharma (RDHL) Awarded Judgment of Approximately $8M Plus Costs by NY Supreme Court
Dec 2, 2024 07:00AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All